Tamarack Biotics Announces TruActive Clinical Trial

Tamarack Biotics announces the initiation of a clinical trial to determine TruActive’s benefits in restoring immune health to patients undergoing chemotherapy. TruActive should strengthen immune function and keep people well. Additionally, it has been hypothesized that TruActive may reduce toxicity and potentially increase the efficacy of the new class of immune modulating cancer drugs.

We are very excited to participate in this exciting research.

Previous
Previous

Immunosenescence Clinical Trial Paper Published

Next
Next

Science, Sweeteners, & Safe Raw Milk